跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 28, 2025
Approval ID
7a57633a2c3b7070
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
7a57633a2c3b7070
Drug Cima Aemps Name
AVANCORT DUO 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
90298
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2025-04-28
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
137 microgramos/50 microgramos/aplicación
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
AZELASTINA HIDROCLORURO
1 mg
FLUTICASONA PROPIONATO
0,365 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 28, 2025
Approval ID
7a57633a2c3b7070
Type
Standard
Back to CIMA-AEMPS Approvals